PubRank

C W Putnam

Author PubWeight™ 159.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet 1976 8.11
2 Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc 1974 5.53
3 Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet 1971 5.24
4 Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery 1977 4.08
5 The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet 1973 3.84
6 Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet 1976 3.74
7 Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet 1975 3.66
8 Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet 1980 3.64
9 Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg 1970 3.48
10 Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery 1972 3.26
11 Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev 1971 2.94
12 Acute neurological complications after liver transplantation with particular reference to intraoperative cerebral air embolus. Ann Surg 1978 2.48
13 Portal diversion for the treatment of glycogen storage disease in humans. Ann Surg 1973 2.44
14 Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet 1968 2.23
15 Immunosuppression, liver injury, and hepatitis in renal, hepatic, and cardiac homograft recipients: with particular reference to the Australia antigen. Ann Surg 1971 2.14
16 RAD53, DUN1 and PDS1 define two parallel G2/M checkpoint pathways in budding yeast. EMBO J 1999 2.05
17 Infections in recipients of liver homografts. N Engl J Med 1968 1.92
18 The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons. Surg Gynecol Obstet 1975 1.91
19 Urological complications in 216 human recipients of renal transplants. Ann Surg 1970 1.90
20 Recovery from "hepatorenal syndrome" after orthotopic liver transplantation. N Engl J Med 1973 1.85
21 Fungus infections after liver transplantation. Ann Surg 1977 1.81
22 Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen. Arch Surg 1979 1.80
23 Cyclophosphamide and human organ transplantation. Lancet 1971 1.77
24 Alopecia, ascites, and incomplete regeneration after 85 to 90 per cent liver resection. Am J Surg 1975 1.72
25 Portacaval shunt in hyperlipoproteinaemia. Lancet 1973 1.66
26 Intraportal insulin protects from the liver injury of portacaval shunt in dogs. Lancet 1975 1.55
27 Liver replacement for alpha1-antitrypsin deficiency. Surgery 1977 1.53
28 A trial with heterologous antilymphocyte globulin in man. Transplant Proc 1969 1.51
29 Clinical and pathologic observations after orthotopic transplantation of the human liver. Surg Gynecol Obstet 1969 1.51
30 Abdominal wall hernias in patients with abdominal aortic aneurysmal versus aortoiliac occlusive disease. Am J Surg 1995 1.50
31 Infections complicating orthotopic liver transplantation: a study emphasizing graft-related septicemia. Arch Surg 1976 1.50
32 Use of a U tube in the treatment of biliary disease. Surg Gynecol Obstet 1976 1.40
33 Hepatic ischemia, caused by celiac axis compression, complicating pancreaticoduodenectomy. Ann Surg 1993 1.36
34 The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs. Surg Gynecol Obstet 1975 1.33
35 Current policies in hepatic transplantation: candidacy of patients with alcoholic liver disease or preformed antidonor antibodies and a reappraisal of biliary duct reconstruction. Ann N Y Acad Sci 1975 1.30
36 Liver transplantation of Budd-Chiari syndrome. JAMA 1976 1.26
37 Pathology of liver transplantation. Transplantation 1976 1.21
38 A decade followup in early cases of renal homotransplantation. Ann Surg 1974 1.16
39 Metabolism of 2,2',3,3',6,6'-hexachlorobiphenyl and 2,2',4,4',5,5'-hexachlorobiphenyl by human hepatic microsomes. Biochem Pharmacol 1983 1.16
40 Clinical liver transplantation. Transplant Rev 1969 1.13
41 Hepatic encephalopathy and light and electron micrographic changes of the baboon liver after portal diversion. Ann Surg 1976 1.11
42 Progress in liver transplantation. World J Surg 1977 1.07
43 Detection of Australia antigen by biological assay in 'Au negative' kidney homograft recipients with hepatic dysfunction. Clin Exp Immunol 1972 1.06
44 Cyclophosphamide for clinical renal and hepatic transplantation. Transplant Proc 1973 1.04
45 Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis. Infection 1982 1.04
46 Factors influencing the safety of colostomy closure in the elderly. J Surg Res 1994 1.02
47 Letter: Follow-up of patient with portacaval shunt for the treatment of hyperlipidaemia. Lancet 1974 1.00
48 Indications for orthotopic liver transplantation: with particular reference to hepatomas, biliary atresia, cirrhosis, Wilson's disease and serum hepatitis. Transplant Proc 1971 1.00
49 Thymectomy and renal homotransplantation. Clin Exp Immunol 1970 0.98
50 Interspecies reactivity and intraspecies specificity of antilymphoid globulin. Surgery 1967 0.97
51 Pediatric cadaver kidneys for transplantation. Surgery 1978 0.97
52 Kidney transplantation. Modern trends in kidney transplantation. Transplant Proc 1977 0.97
53 Net histocompatibility ratios (NHR) for clinical transplantation. Transplant Proc 1971 0.97
54 Personal experience with orthotopic liver transplantation. Transplant Proc 1972 0.96
55 Correction of coagulation in the hemophilic dog by transplantation of lymphatic tissue. Surgery 1974 0.94
56 Cross-reactivity studies of horse, goat and rabbit anti-lymphocyte globulin. Clin Exp Immunol 1970 0.92
57 Major hepatic resection and portal pressure. Surg Gynecol Obstet 1977 0.91
58 Eight- to ten-year follow-up in early cases of renal homotransplantation. Transplant Proc 1973 0.91
59 Techniques of ultrasonic dissection in resection of the liver. Surg Gynecol Obstet 1983 0.91
60 Immunosuppression with cyclophosphamide in the dog. Clin Exp Immunol 1975 0.89
61 Prolactin is a tumor promoter in rat liver. Life Sci 1985 0.88
62 The contribution of inducible nitric oxide and cytomegalovirus to the stability of complex carotid plaque. J Vasc Surg 1999 0.88
63 Letter: Portacaval shunt in hyperlipidaemia. Lancet 1974 0.88
64 The acutely affected abdomen in paraplegic spinal cord injury patients. Ann Surg 1990 0.87
65 Influence of spousal opinions on residency selection. Am J Surg 1992 0.87
66 The effects of improved hemodynamics on aortic dimensions in patients undergoing heart transplantation. J Vasc Surg 1994 0.86
67 Prolactin-dependent mitogenesis in Nb 2 node lymphoma cells: effects of immunosuppressive cyclopeptides. J Immunol 1987 0.85
68 Helping residents' families cope. Acad Med 1992 0.85
69 Dynamic organ culture of precision liver slices for in vitro toxicology. Life Sci 1985 0.85
70 The prospect of organ transplantation in cancer surgery. Proc Natl Cancer Conf 1970 0.85
71 Cellular origin and rate of endothelial cell coverage of PTFE grafts. J Surg Res 1995 0.83
72 Putative vascular endothelial cell chemotactic factors: comparison in a standardized migration assay. J Surg Res 1993 0.83
73 Prolactin administration stimulates rat hepatic DNA synthesis. Biochem Biophys Res Commun 1986 0.83
74 A hundred years of the hepatotrophic controversy. Ciba Found Symp 1977 0.82
75 Portacaval shunt and hyperlipidemia. Arch Surg 1978 0.82
76 Insulin, glucagon, and the control of hepatic structure, function, and capacity for regeneration. Metabolism 1976 0.82
77 Long-term results of cardiac transplantation in patients older than sixty years. UTAH Cardiac Transplant Program. J Thorac Cardiovasc Surg 1996 0.82
78 Modification of established rejection of canine kidney and liver homografts with antilymphocyte gamma-G globulin. Surgery 1969 0.82
79 Valproic acid hepatotoxicity in human liver slices. Drug Chem Toxicol 1991 0.81
80 Peripheral vascular disease in heart transplant recipients. J Vasc Surg 1992 0.81
81 Venous complications of sclerotherapy for esophageal varices. Am J Surg 1988 0.81
82 The hydroxylation, dechlorination, and glucuronidation of 4,4'-dichlorobiphenyl (4-DCB) by human hepatic microsomes. Biochem Pharmacol 1984 0.80
83 Prolactin stimulation of ornithine decarboxylase and mitogenesis in Nb2 node lymphoma cells: the role of protein kinase C and calcium mobilization. Immunopharmacology 1986 0.80
84 Hepatic protein kinase C: translocation stimulated by prolactin and partial hepatectomy. Life Sci 1987 0.80
85 Prolactin-provoked alterations of cytosolic, membrane, and nuclear protein kinase C following partial hepatectomy. Dig Dis Sci 1991 0.79
86 Prolactin as a mammalian mitogen and tumor promoter. Adv Enzyme Regul 1988 0.79
87 Identification of prolactin receptors in hepatic nuclei. Arch Biochem Biophys 1992 0.79
88 Gastric outlet obstruction caused by traumatic pseudoaneurysm of superior mesenteric artery. Surgery 1990 0.79
89 Letter: Liver transplantation for Wilson's disease. Lancet 1975 0.79
90 Current status of liver transplantation. South Med J 1977 0.79
91 Transplantation in children. Surg Clin North Am 1976 0.79
92 Transplantation of the liver. Surg Clin North Am 1977 0.79
93 Iliac-enteric fistula following Dacron patch angioplasty. Ann Vasc Surg 1991 0.79
94 Bench surgery and renal autotransplantation in the pediatric patient. J Pediatr Surg 1975 0.79
95 The possible role of cyclosporine in nonocclusive mesenteric ischemia in a renal transplant patient. Transplantation 1991 0.79
96 Suramin, a protein kinase C inhibitor, impairs hepatic regeneration. Cell Growth Differ 1994 0.78
97 The hepatotoxicities of endotoxin and ethanol comparisons in vitro using the precision-cut rat liver slice model. Life Sci 1994 0.78
98 Portacaval shunt for glycogen storage disease and hyperlipidaemia. Ciba Found Symp 1977 0.78
99 Attenuation of hyperacute xenograft rejection in unmodified host by extracorporeal plasma perfusion. Transplantation 1977 0.78
100 In vivo induction of rat hepatic ornithine decarboxylase and plasminogen activator by 12-O-tetradecanoylphorbol 13-acetate. Biochim Biophys Acta 1985 0.77
101 Ex vivo renal perfusion and autotransplantation in treatment of calculous disease or abdominal aortic aneurysm. Urology 1975 0.77
102 Rapid elevation of plasminogen activator activity in rat tissues by prolactin. Biochem Biophys Res Commun 1984 0.77
103 The nature of antiplatelet activity in antilymphoblast ALG--with special reference to cross-reacting antibody, immunochemical characterization, and Coombs' positive thrombocytopenia in ALG-treated renal recipients. Clin Exp Immunol 1972 0.77
104 Peripheral benzodiazepine binding sites in Nb 2 node lymphoma cells: effects on prolactin-stimulated proliferation and ornithine decarboxylase activity. Eur J Pharmacol 1989 0.76
105 Prolactin-stimulated mitogenesis in the Nb2 rat lymphoma cell: lack of protoporphyrin IX effects. Life Sci 1990 0.76
106 Biotransformation activity in vitrified human liver slices. Cryobiology 1991 0.76
107 Unsuccessful attempts to control hyperacute rejection of human renal homografts with F(ab') 2 and citrate organ pretreatment. Transplantation 1973 0.76
108 Incidence and histologic characteristics of blebs in patients with abdominal aortic aneurysms. J Vasc Surg 1996 0.76
109 Orthotopic liver transplantation in man. Transplant Proc 1969 0.76
110 Impaired platelet function in glucose-6-phosphatase deficiency. J Pediatr 1974 0.75
111 Portal diversion. Treatment for glycogen storage disease and hyperlipemia. JAMA 1975 0.75
112 Hepatic transplantation, 1975. Postgrad Med J 1976 0.75
113 Pancreatic pseudocyst after distal splenorenal shunt. Ann Surg 1981 0.75
114 Surgical approaches to primary and metastatic liver neoplasms. Int J Radiat Oncol Biol Phys 1976 0.75
115 The reduction of antigenicity of heterologous antilymphocyte serum with acid Taka-protease. Clin Exp Immunol 1972 0.75
116 Failure of renal homograft protection with RNA pretreatment. Transplantation 1978 0.75
117 Chronic immunosuppression, Australia antigenemia, and hepatitis. Transplant Proc 1972 0.75
118 Renal transplantation under cyclophosphamide. Transplant Proc 1972 0.75
119 A reproducible large animal model of acute hepatic failure. Curr Surg 1985 0.75
120 Past experience and future studies with antilymphocyte globulin in recipients of kidney homografts. Postgrad Med J 1976 0.75
121 Detection of porcine-specific canine antibodies by a radioimmunological technique. Transplantation 1977 0.75
122 Renal homotransplantation. I. Curr Probl Surg 1974 0.75
123 Phorbol ester-induced attenuation of tissue DNA synthesis: antagonism by prolactin in liver and thymus. Biochem Pharmacol 1989 0.75
124 Solubilization of a peripheral type benzodiazepine binding site from rat liver. Proc West Pharmacol Soc 1988 0.75
125 Vitamin E levels in human atherosclerotic plaque: the influence of risk factors. Atherosclerosis 1996 0.75
126 Binding characterization of the peripheral type benzodiazepine receptor (P-BZ) in rat liver. Proc West Pharmacol Soc 1988 0.75
127 A new dialysis access device. Surg Gynecol Obstet 1983 0.75
128 Simplified biopsy of the liver in dogs. Surg Gynecol Obstet 1977 0.75
129 The radiology of ex vivo renal perfusion and autotransplantation. AJR Am J Roentgenol 1977 0.75
130 Solubilization and characterization of the liver peripheral-type benzodiazepine receptor. J Pharmacol Exp Ther 1989 0.75
131 In-vitro hepatotoxicity of three dichlorobenzene isomers in human liver slices. Hum Exp Toxicol 1991 0.75
132 Aminophylline antagonizes the neuromuscular blockade of pancuronium but not vecuronium. Crit Care Med 1991 0.75
133 The mechanism of hepatoprotection by epsilon aminocaproic acid and putrescine. Surgery 1984 0.75
134 Transplantation of the liver. Prog Liver Dis 1970 0.75
135 Improved sterile technique diminishes the incidence of positive line cultures in cardiovascular patients. J Surg Res 1992 0.75
136 Clinical experience with horse antihuman ALG. Transplant Proc 1972 0.75
137 The effect of alcohol in isolated blunt splenic trauma. J Trauma 1990 0.75
138 Embryological development of peripheral benzodiazepine binding sites in the chick liver. Proc West Pharmacol Soc 1988 0.75
139 A new colorimetric assay for plasminogen activator activity. Proc West Pharmacol Soc 1983 0.75
140 Effect of surgical manipulation of polytetrafluoroethylene grafts on microstructural properties and healing characteristics. Am J Surg 1992 0.75
141 Prolactin as a hepatotrophic hormone. Transplant Proc 1988 0.75
142 Hyperpyrexia-related ventricular tachycardia during OKT3 induction therapy. Transplantation 1992 0.75
143 Cryopreservation of pig and human liver slices. Cryobiology 1991 0.75